Filing Details
- Accession Number:
- 0001192482-15-000020
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2015-02-05 16:58:01
- Reporting Period:
- 2015-02-04
- Filing Date:
- 2015-02-05
- Accepted Time:
- 2015-02-05 16:58:01
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1609351 | Spark Therapeutics Inc. | ONCE | Biological Products, (No Disgnostic Substances) (2836) | 462654405 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1632060 | Foundation Philadelphia Of Hospital Children's | 3737 Market Street Suite 1300 Philadelphia PA 19104 | No | No | Yes | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2015-02-04 | 1,000,000 | $0.00 | 5,943,629 | No | 4 | C | Direct | |
Common Stock | Acquisiton | 2015-02-04 | 2,795,031 | $0.00 | 8,738,660 | No | 4 | C | Direct | |
Common Stock | Acquisiton | 2015-02-04 | 61,552 | $0.00 | 8,800,212 | No | 4 | C | Direct | |
Common Stock | Acquisiton | 2015-02-04 | 100,000 | $23.00 | 8,900,212 | No | 4 | P | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | C | Direct | |
No | 4 | C | Direct | |
No | 4 | C | Direct | |
No | 4 | P | Direct |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Common Stock | Series A Preferred Stock | Disposition | 2015-02-04 | 1,000,000 | $0.00 | 1,000,000 | $0.00 |
Common Stock | Series B Preferred Stock | Disposition | 2015-02-04 | 2,795,031 | $0.00 | 2,795,031 | $0.00 |
Common Stock | Accrued Preferred Stock Dividends | Disposition | 2015-02-04 | 61,552 | $0.00 | 61,552 | $0.00 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
0 | No | 4 | C | Direct | ||
0 | No | 4 | C | Direct | ||
0 | No | 4 | C | Direct |
Footnotes
- Shares of Series A Preferred Stock automatically converted into shares of the Common Stock on a one-for-one basis without payment of further consideration upon the closing of the Issuer's initial public offering on February 4, 2015.
- Shares of Series B Preferred Stock automatically converted into shares of the Common Stock on a one-for-one basis without payment of further consideration upon the closing of the Issuer's initial public offering on February 4, 2015.
- Paid-in-kind dividends declared and paid on the Series A Preferred Stock and Series B Preferred Stock automatically converted into shares of Common Stock on a one-for-one basis without payment of further consideration upon the closing of the issuer's initial public offering on February 4, 2015.